That's crucial, since the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective. In other words, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error procedure (the legacy report prediction). However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a development almost no one saw. But it's going to have profound ramifications for curing disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of investment opportunities in this space, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown 2021 stock predictions). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps significantly prior to going greater - brownstone research stock. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were primarily educating readers. But that's not the big concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown biotech stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are many great personal business on the edge of striking the general public markets And I have actually been dealing with a new method for you to invest even before these business go public.
This chance has actually been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to book your area free of charge.
Emma Walsh here, handling editor of the Journal. Routine Journal readers know that tech isn't our typical beat (united arab emirates). And when it pertains to tech investing, we leave it to the specialists. Luckily, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing professionals we understand (jeff brown biotech stock pick for 2020). In fact, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and predict what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These patterns are experiencing exponential development and creating amazing opportunities for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. last week. However regardless of what lots of readers may believe, this is a trend that's simply starting. Although the COVID-19 pandemic disrupted supply chains in 2015, an excellent 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown biotech genome sequencing). Losing two months of production and sales truly impacts the number of 5G gadgets are offered in the fiscal year. When you consider all of that, selling 250 million units is amazing. More importantly, the hold-ups brought on by the pandemic produced a lot of suppressed demand. Which demand is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - social media. Which's not my only 5G forecast When I've spoken about 5G in the past, I have actually explained its 3 different phases.
In Stage 2, 5G devices go on sale. 5G phones and other products start to reach customers. And in Stage Three, 5G services start to be used (diplomatic relations). That's when we begin to see applications working on 5G networks. Consider things like huge multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase Three by this summer season. This starts something of a virtuous cycle: The majority of people don't actually care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open a suite of amazing applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The financial investment opportunities going forward will be huge. Stepping away from 5G, the next essential technology I foresee in 2021 is CRISPR hereditary modifying. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it's one of the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software.
The program can crash or not function properly. CRISPR uses a similar concept but with our genetic code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For years, CRISPR was mostly a specific niche innovation that wasn't well understood. And during that time, there were really only three business running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing real results. We're treating illness and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering amazing returns. This whole market is effectively a greenfield chance.
There's room for numerous business to exist in this area. future report review. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or 3 more genetic editing companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things occurring at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can accurately forecast the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That is essential since the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been an experimental process. Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however several drug therapies produced utilizing this technology. This was one of those breakthroughs that almost nobody noticed. But it's going to have profound implications for curing disease. And, obviously, there will be lots of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back maybe considerably prior to going higher. I've been covering bitcoin for a long time now. Among the first research study reports I ever released was on bitcoin - jeff brown tech stock 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But no one is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. jeff brown 2020 predictions. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info is up to date since February 2021, however we could not individually validate this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to select winning innovation stocks. He invested more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an outstanding perspective on the marketplace. He's constantly on the hunt for new opportunities, and he shares a number of his finest picks in the Near Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he effectively anticipated a few of the greatest economic occasions of the past 20 years. Although he does not appear to launch his picks to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it best whenever, but Jeff Brown's accurate forecasts have earned him legions of devoted followers. That states a lot about his capability. The Near Future Report is released by Brownstone Research, a popular financial research publisher. Brownstone Research uses several research services with a wide variety of specializations - biotech stocks.
The company is likewise connected with Bonner & Partners, another well-respected research study publisher - toxic tech 5 tech darlings. On its website, Brownstone states its objective is to provide retail investors with professional-grade research: "For too long, the very best investment research has actually not been offered to specific financiers. It has actually been normally scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown 2021 predictions. The mission of Brownstone Research study is to make that kind of exclusive research offered to any financiers aiming to acquire an edge in the markets. The goal is easy to provide unique and successful financial investment research discovered nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise acts as the firm's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After years of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout most of America. If you know even a bit about the marketplace, you know that he has a credibility as a King Midas of sorts. jeff brown stock predictions. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. jeff brown 1 biotech company. might be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding 2 innovative technologies: synthetic intelligence and electrical cars and trucks. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving automobiles ever. It's nothing except the automobile market's Holy Grail. As you know, electrical lorries and self-driving automobile stocks have been huge this year, but the Wall Street machine has been big on buzz without much tangible result. In spite of a drastic increase in competition over the previous few years, Brown still thinks Musk has the very best possibility of putting all of it together.
tech might be the magic string that ties everything together. S.A.V. represents Shared Autonomous Car, and it might be the future of transportation. Generally, this innovation would enable you to lease out your car as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the car and press a button on an app that tells the cars and truck to "join the fleet." Next thing you understand, you're relaxing on your couch while your car shuttles ride-sharers around town. Best of all, you get to keep a substantial piece of the revenues. It sounds insane, but it might be closed than you think.